Marc Carrier/LinkedIn;Caterina E. Marx
/researchgate.net
Apr 17, 2026, 12:44
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Managing recurrent VTE despite anticoagulation in patients with cancer remains one of the most challenging scenarios in thrombosis care.
This ‘How I Treat’ review outlines a pragmatic potential approach:
- Confirm true recurrence (versus residual clot)
- Assess adherence, drug interactions, and absorption
- Optimize anticoagulation (LMWH escalation or switch)
Despite these strategies, recurrence and bleeding risks remain substantial highlighting the urgent need for more high-quality data.”
Title: How I treat breakthrough thrombosis in patients with cancer
Authors: Caterina E. Marx, Marc Carrier
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination